Pliant Therapeutics is up a bit on the day, funds flowing in kept the price up 1.01% since yesterday.
Currently PLRX isn't at a clear support/resistance line that seems tradable. Pliant Therapeutics hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. PLRX might find some support at the 36.26 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts feel fairly neutral on the prospects for Pliant Therapeutics but a little more positive than negative. The current Analysts Sentiment Score is 23.44. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. On 2024-05-07 HC Wainwright reiterated their rating of Buy and added a price target of $36.00. Needham & Company LLC announced that they are reiterating a rating of Buy on 2024-05-07 and they set their price target at $38.00. Oppenheimer gave a boost to their price target and moved to $48.00 from $47.00 on 2024-05-07. Royal Bank of Canada announced a lowering of their price target to $45.00 from $54.00 on 2024-05-07. On 2023-12-08 Wells Fargo & Company initiated their coverage and rated as Overweight and they set their price target at $41.00.Leerink Partnrs reiterated a rating of Outperform on 2023-10-16. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2023-08-22 and they set their price target at $63.00. JPMorgan Chase & Co. provided a price target boost of 2.13% to $48.00 from $47.00 on 2023-08-10. Canaccord Genuity Group initiated a rating of Buy on 2023-05-18 and provided a price target of $48.00.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| PLRX | 23.44 | 25.57 | 0 | 24.94 | -3.64 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| PLRX | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| PLRX | 10.35 | %10.8307 | 10.1 | -1.914 | 6480000 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| PLRX |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SAGE | Sage Therapeutics, Inc | 0.82 | 6.60 | 8.16 | -39.46 | -38.67 | -56.66 | -73.49 | 31 | -168.21 | -178.82 | -69.30 | -149709.64 | -1968.67 | 0 | 0 | 12.6533 |
| SDGR | Schrodinger, Inc. Common | 0.74 | 2.31 | 14.32 | 13.45 | -0.90 | -5.74 | -32.88 | 85 | -6.47 | -10.49 | -56.17 | -13879.86 | -3955.08 | 0 | 0 | 9.02067 |
| EDIT | Editas Medicine, Inc. Com | 0.72 | 2.95 | -3.17 | -25.15 | -34.76 | -54.14 | -76.94 | 47 | -172.46 | -138.74 | -176.20 | -57394.91 | 2.09 | 0 | 0 | 16.4101 |
| RCKT | Rocket Pharmaceuticals, I | 0.7 | 10.32 | 3.29 | -19.33 | -25.15 | -32.62 | -36.58 | 29 | -88.38 | -65.83 | -77.27 | -23028.56 | -99.38 | 0 | 0 | 9.12889 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
